Official websites use .gov
A
.gov website belongs to an official government
organization in the United States.
Secure .gov websites use HTTPS
A
lock (
) or https:// means you’ve safely connected to
the .gov website. Share sensitive information only on official,
secure websites.
The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.
The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.
The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.
The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.
The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.
The video describes ways to effectively manage active TB by providing information on TB testing, diagnosis, and treatment.
This information sheet discusses TB testing using the Mantoux tuberculin skin test (TST) to determine whether an individual is infected with Mycobacterium TB. It discusses how the TST is administered, how it is read, how TST reactions are interpreted the classification of the TST skin test reaction, what are false-positive and false-negative reactions, who can receive a TST and how often the test can be repeated, what is a boosted reaction, why two-step testing is conducted, and whether TSTs can be given to persons receiving vaccinations.
This video illustrates the interactions between TB and HIV, including their impact on the immune system, TB testing, and TB treatment.
The information sheet discusses targeted TB testing, the decision to focus on groups at highest risk for latent TB infection (LTBI) and advises appropriate treatment and treatment completion to prevent LTBI progressing to active disease. It explains tuberculin skin testing (TST) and the test reactions that indicate whether an individual has LTBI; lists the criteria for classifying positive TST reactions; and describes persons at risk for developing TB disease including clinical conditions that increase the risk of LTBI becoming TB disease.
The animation educates viewers on topics related to drug-resistant TB and multidrug-resistant TB, such as treatment plans, basic information on multidrug-resistant TB, and the importance of medication adherence.
